CRDOHIGH SIGNALOPPORTUNITY10-K

CRDO experienced explosive growth with revenue more than doubling to $437M and swinging from a $28M net loss to $52M profit, accompanied by dramatic increases across all balance sheet items.

This represents a fundamental transformation of the business with revenue growth of 126% indicating either major market expansion, successful product launches, or potential acquisitions. The swing from operating losses to strong profitability demonstrates effective operational leverage and scalability of the business model.

Comparing 2025-07-02 vs 2024-06-24View on EDGAR →
FINANCIAL ANALYSIS

CRDO delivered exceptional growth across all financial metrics, with revenue more than doubling to $437M while achieving a remarkable turnaround from a $28M net loss to $52M profit. Balance sheet items expanded proportionally, with cash increasing 253% to $236M, inventory growing 248% to $90M, and receivables rising 172% to $162M, all indicating robust business scaling. The company also moved from a 52-week to 53-week fiscal year in 2025, though this accounts for only a small portion of the dramatic growth, suggesting genuine business expansion and operational improvements that position the company very favorably for continued growth.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+283.9%
-$28.4M$52.2M

Net income grew 283.9% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+253%
$66.9M$236.3M

Cash position surged 253% — strong cash generation or capital raise providing significant financial cushion.

Inventory
Balance Sheet
+247.5%
$25.9M$90.0M

Inventory surged 247.5% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Operating Income
P&L
+200.2%
-$37.1M$37.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Accounts Receivable
Balance Sheet
+171.8%
$59.7M$162.1M

Receivables surged 171.8% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Current Liabilities
Balance Sheet
+141.4%
$44.6M$107.7M

Current liabilities surged 141.4% — significant near-term obligations; verify ability to meet short-term debt.

Gross Profit
P&L
+136.9%
$119.4M$282.9M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Capital Expenditure
Cash Flow
+130.4%
$15.7M$36.1M

Capital expenditure jumped 130.4% — major investment cycle underway; assess returns on deployment.

Revenue
P&L
+126.3%
$193.0M$436.8M

Strong top-line growth of 126.3% — accelerating demand or successful expansion into new markets.

Total Liabilities
Balance Sheet
+106.8%
$61.7M$127.7M

Liabilities grew 106.8% — significant increase in debt or obligations, assess impact on financial flexibility.

LANGUAGE CHANGES
NEW — 2025-07-02
PRIOR — 2024-06-24
ADDED
The registrant had 171,641,835 ordinary shares outstanding as of June 13, 2025.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 104 Item 9A.
The Company s fiscal year is a 52- or 53-week period ending on the Saturday closest to April 30.
The additional week in a 53-week year is added to the first quarter, making such quarter consist of 14 weeks.
Accordingly, every fifth or sixth fiscal year will have a 53-week period.
+7 more — sign up free →
REMOVED
The registrant had 165,185,407 ordinary shares outstanding as of June 17, 2024.
Changes in and Disagreements w ith Accountants on Accounting and Financial Disclosure 105 Item 9A.
Effective May 1, 2022, the Company changed its fiscal year to a 52- or 53-week period ending on the Saturday closest to April 30.
Our fiscal year ending April 27, 2024 (fiscal 2024) is a 52-week fiscal year.
The first quarter of fiscal 2024 ended on July 29, 2023, the second quarter ended on October 28, 2023 and the third quarter ended on January 27, 2024.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
IRIXHIGHIRIX demonstrated a dramatic operational turnaround with revenue surging 283% wh...
2026-04-02
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →